Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2013, Article ID 782573, 9 pages
http://dx.doi.org/10.1155/2013/782573
Research Article

Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

1Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USA
2Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA
3Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

Received 29 November 2012; Accepted 18 January 2013

Academic Editor: Edward A. Abraham

Copyright © 2013 Juan C. Valerio-Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [37 citations]

The following is the list of published articles that have cited the current article.

  • Karolina Akinosoglou, and Dimitrios Alexopoulos, “Use of antiplatelet agents in sepsis: A glimpse into the future,” Thrombosis Research, 2013. View at Publisher · View at Google Scholar
  • Cheng-Ming Tsao, Shung-Tai Ho, and Chin-Chen Wu, “Coagulation abnormalities in sepsis,” Acta Anaesthesiologica Taiwanica, 2014. View at Publisher · View at Google Scholar
  • Sacha F. de Stoppelaar, Cornelis van 't Veer, and Tom van der Poll, “The role of platelets in sepsis,” Thrombosis and Haemostasis, vol. 112, no. 4, pp. 666–677, 2014. View at Publisher · View at Google Scholar
  • Vincent Mémier, Fanny Vardon, Aemilia Jacquemin, Vincent Minville, Pierre Sié, and Bernard Payrastre, “Cinétique d’activation plaquettaire et d’interactions leuco-plaquettaires, et influence de l’aspirine au cours d’un sepsis expérimental,” Anesthésie & Réanimation, vol. 1, pp. A208–A209, 2015. View at Publisher · View at Google Scholar
  • Xiaohan Xu, and Bingwei Sun, “Platelet granule secretion mechanisms: Are they modified in sepsis?,” Thrombosis Research, 2015. View at Publisher · View at Google Scholar
  • Min-Juei Tsai, Shuo-Ming Ou, Chia-Jen Shih, Pei-wen Chao, Lan-Fu Wang, Yu-Ning Shih, Szu-Yuan Li, Shu-Chen Kuo, Yen-Tao Hsu, and Yung-Tai Chen, “Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study,” Intensive Care Medicine, 2015. View at Publisher · View at Google Scholar
  • Philip Toner, Danny Francis McAuley, and Murali Shyamsundar, “Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome,” Critical Care, vol. 19, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kortbaoui, Allou, Allyn, Guglielminotti, Bussienne, Montravers, Martinet, Vandroux, Desmard, and Augustin, “Pattern and consequences of cardiologic medications management for patients with elevated troponin I upon admission into an intensive care unit not linked to type 1 acute myocardial infarction: A prospective observational cohort study,” Annales Pharmaceutiques Francaises, vol. 75, no. 4, pp. 285–293, 2016. View at Publisher · View at Google Scholar
  • Lijun Wang, Heng Li, Xiaofei Gu, Zhen Wang, Su Liu, and Liyong Chen, “Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis,” Plos One, vol. 11, no. 5, 2016. View at Publisher · View at Google Scholar
  • Maryse A. Wiewel, Sacha F. de Stoppelaar, Lonneke A. van Vught, Jos F. Frencken, Arie J. Hoogendijk, Peter M. C. Klein Klouwenberg, Janneke Horn, Marc J. Bonten, Aeilko H. Zwinderman, Olaf L. Cremer, Marcus J. Schultz, and Tom van der Poll, “Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-,” Intensive Care Medicine, vol. 42, no. 3, pp. 352–360, 2016. View at Publisher · View at Google Scholar
  • Min-Juei Tsai, Chia-Jen Shih, and Yung-Tai Chen, “Association of prior antiplatelet agents with mortality in sepsis patients,” Intensive Care Medicine, 2016. View at Publisher · View at Google Scholar
  • Shmeylan A. Al Harbi, Hani M. Tamim, Hasan M. Al-Dorzi, Musharaf Sadat, and Yaseen M. Arabi, “Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study,” Bmc Pharmacology & Toxicology, vol. 17, 2016. View at Publisher · View at Google Scholar
  • Rahajeng N. Tunjungputri, Esther Peters, Andre Van Der Ven, Quirijn De Mast, Peter Pickkers, and Philip G. De Groot, “Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans,” Thrombosis and Haemostasis, vol. 116, no. 6, pp. 1111–1121, 2016. View at Publisher · View at Google Scholar
  • Jecko Thachil, and Theodore E. Warkentin, “How do we approach thrombocytopenia in critically ill patients?,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Undurti N Das, “Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS,” Lipids in Health and Disease, vol. 15, no. 1, 2016. View at Publisher · View at Google Scholar
  • Divyanshu Mohananey, Harish Ramakrishna, Pedro A. Villablanca, Muhammad S. Ali, Rohit Kumar, Anushka Baruah, Nirmanmoh Bhatia, Sahil Agrawal, Zeeshan Hussain, Fadi E. Shamoun, John T. Augoustides, and Jaskaran Sethi, “Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis,” Annals of Cardiac Anaesthesia, vol. 19, no. 4, pp. 626–637, 2016. View at Publisher · View at Google Scholar
  • Devadoss J. Samuvel, Anandakumar Shunmugavel, Avtar K. Singh, Inderjit Singh, and Mushfiquddin Khan, “S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis,” Journal of Pharmacy and Pharmacology, pp. 1310–1319, 2016. View at Publisher · View at Google Scholar
  • Hind Hamzeh-Cognasse, Fabrice Cognasse, Adrien Chabert, and Olivier Garraud, “Platelets and coagulation during bacterial infections,” Hematologie, vol. 23, no. 4, pp. 236–242, 2017. View at Publisher · View at Google Scholar
  • Michael B. Clay, Hina Jamali, Florence G. Rothenberg, and Robin H Vandivier-Pletsch, “Systematic review of β blocker, aspirin, and statin in critically ill patients: Importance of severity of illness and cardiac troponin,” Journal of Investigative Medicine, vol. 65, no. 4, pp. 747–753, 2017. View at Publisher · View at Google Scholar
  • Maryse A. Wiewel, Tom Van Der Poll, Arie J. Hoogendijk, Jos F. Frencken, Aeilko H. Zwinderman, Janneke Horn, Olaf L. Cremer, Marcus J. Schultz, Lonneke A. Van Vught, Brendon P. Scicluna, and Marc J. Bonten, “Prior Use of Calcium Channel Blockers Is Associated with Decreased Mortality in Critically Ill Patients with Sepsis: A Prospective Observational Study,” Critical Care Medicine, vol. 45, no. 3, pp. 454–463, 2017. View at Publisher · View at Google Scholar
  • Shuhua Luo, Yabo Wang, Qi An, Hao Chen, Junfei Zhao, Jie Zhang, Wentong Meng, and Lei Du, “Platelets protect lung from injury induced by systemic inflammatory response,” Scientific Reports, vol. 7, pp. 42080, 2017. View at Publisher · View at Google Scholar
  • Antoine Dewitte, Sébastien Lepreux, Julien Villeneuve, Claire Rigothier, Christian Combe, Alexandre Ouattara, and Jean Ripoche, “Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?,” Annals of Intensive Care, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Xavier Delabranche, Ferhat Meziani, and Julie Helms, “Immunohaemostasis: a new view on haemostasis during sepsis,” Annals of Intensive Care, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • James Trauer, Stephen Muhi, Emma S. McBryde, Shmeylan A. Al Harbi, Yaseen M. Arabi, Andrew J. Boyle, Rodrigo Cartin-Ceba, Wei Chen, Yung-Tai Chen, Marco Falcone, Ognjen Gajic, Jack Godsell, Michelle Ng Gong, Daryl Kor, Wolfgang Lösche, Daniel F. McAuley, Hollis R. O’Neal, Michael Osthoff, Gordon P. Otto, Maik Sossdorf, Min-Juei Tsai, Juan C. Valerio-Rojas, Tom van der Poll, Francesco Violi, Lorraine Ware, Andreas F. Widmer, Maryse A. Wiewel, Johannes Winning, and Damon P. Eisen, “Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths,” Critical Care Medicine, vol. 45, no. 11, pp. 1871–1879, 2017. View at Publisher · View at Google Scholar
  • Elisabetta Greco, Enrico Lupia, Ornella Bosco, Barbara Vizio, and Giuseppe Montrucchio, “Platelets and Multi-Organ Failure in Sepsis,” International Journal of Molecular Sciences, vol. 18, no. 10, pp. 2200, 2017. View at Publisher · View at Google Scholar
  • Damon P. Eisen, Elizabeth M. Moore, Karin Leder, John J. McNeil, Rory Wolfe, Jessica Lockery, Emma S. McBryde, David Pilcher, and Robyn L. Woods, “AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol,” BMJ Open, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Michael Yaroustovsky, Ekaterina Rogalskaya, Marina Plyushch, Ludmila Klimovich, Nataliya Samsonova, and Marina Abramyan, “The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis,” International Journal of Inflammation, vol. 2017, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Adrien Chabert, Hind Hamzeh-Cognasse, Fabrice Cognasse, and Olivier Garraud, “Platelets and coagulation during bacterial infections,” Sang Thrombose Vaisseaux, vol. 29, no. 2, pp. 61–67, 2017. View at Publisher · View at Google Scholar
  • Kate Lambrechts, Sébastien de Maistre, Jacques H. Abraini, Jean-Eric Blatteau, Jean-Jacques Risso, and Nicolas Vallée, “Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?,” Frontiers in Physiology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Elizabeth A. Middleton, Matthew T. Rondina, Hansjorg Schwertz, and Guy A. Zimmerman, “Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome,” American Journal of Respiratory Cell and Molecular Biology, vol. 59, no. 1, pp. 18–35, 2018. View at Publisher · View at Google Scholar
  • Fangbing Du, Pan Jiang, Shengteng He, Dongming Song, and Feng Xu, “Antiplatelet Therapy for Critically Ill Patients,” Shock, vol. 49, no. 6, pp. 616–624, 2018. View at Publisher · View at Google Scholar
  • Yuhui Wang, Yaqi Ouyang, Baoyan Liu, Xiaochun Ma, and Renyu Ding, “Platelet activation and antiplatelet therapy in sepsis: A narrative review,” Thrombosis Research, 2018. View at Publisher · View at Google Scholar
  • Joann Hsu, Justin X. Moore, Henry E. Wang, John P. Donnelly, Ninad S. Chaudhary, Monika M. Safford, and Junghyun Kim, “Aspirin use and long-term rates of sepsis: A population-based cohort study,” PLoS ONE, vol. 13, no. 4, 2018. View at Publisher · View at Google Scholar
  • Yingqin Wang, Ming Zhong, Zhichao Wang, Jieqiong Song, Wei Wu, and Duming Zhu, “The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis,” Critical Care, vol. 22, no. 1, 2018. View at Publisher · View at Google Scholar
  • Yaqi Ouyang, Yuhui Wang, Baoyan Liu, Xiaochun Ma, and Renyu Ding, “Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis,” Journal of Critical Care, 2018. View at Publisher · View at Google Scholar
  • Akiko Konishi, Shosaku Nomura, and Michiomi Shimizu, “Examination of biomarker expressions in sepsis-related DIC patients,” International Journal of General Medicine, vol. 11, pp. 353–361, 2018. View at Publisher · View at Google Scholar
  • Seiichi Munesue, Tetsuo Ohta, Kozo Nomura, Tomoharu Miyashita, Yasuhiko Yamamoto, Ai Harashima, Hideo Takayama, and Sachio Fushida, “Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage,” Journal of Surgical Research, vol. 234, pp. 132–138, 2019. View at Publisher · View at Google Scholar